Background & Purpose
Connecting all healthcare providers to the national drug register is important, but technical and practical challenges made it necessary to postpone certain reporting requirements to ensure patient safety.
The Decision
The Swedish parliament approved the government's proposal to delay the obligation to report specific prescription reasons and follow-up dates to the national drug register.
Does this affect you?
- Healthcare providers in Sweden: Receive extra time until September 2028 to adapt IT systems for reporting specific treatment reasons and follow-up dates.
- Patients in Sweden: Benefit from a more secure and stable implementation process when healthcare systems connect to the national drug register.
- Pharmacies in Sweden: Operate under adjusted timelines for handling standardized prescription data and register updates.
In Practice
- Healthcare providers get more time to adapt their digital systems before reporting specific treatment details.
- The requirement to report why a medication was prescribed is postponed.
- The deadline for reporting the planned follow-up date for a drug treatment is moved forward.
- Other basic parts of the national drug register connection remain unaffected.